Suchergebnisse - "Doehn, Christian"

PubPharm (8)

1

Mode-of-action, efficacy, and safety of a homologous multi-epitope vaccine in a murine model for adjuvant treatment of renal cell carcinoma

enthalten in: European urology | 2009

von Doehn, C. | Esser, N. | Pauels, H. | +5

CommentIn: Eur Urol. 2009 Jul;56(1):132-3. - PMID 18550266

2

Immunotherapy of prostate cancer

enthalten in: European urology | 2008

von Doehn, C.

ErratumIn: Eur Urol. 2008 Jun;53(6):1321

3

Prostate cancer vaccines : current status and future potential

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2008

von Doehn, C. | Böhmer, T. | Kausch, I. | +2

4

Drug evaluation : Therion's rV-PSA-TRICOM + rF-PSA-TRICOM prime-boost prostate cancer vaccine

enthalten in: Current opinion in molecular therapeutics | 2007

von Doehn, C. | Kausch, I. | Böhmer, T. | +2

5

Technology evaluation : Onyvax-P, Onyvax

enthalten in: Current opinion in molecular therapeutics | 2005

von Doehn, C. | Böhmer, T. | Jocham, D.

6

Cytokine and vaccine therapy of kidney cancer

enthalten in: Expert review of anticancer therapy | 2004

von Doehn, C. | Kausch, I. | Melz, S. | +2

7

Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy : phase III, randomised controlled trial

enthalten in: Lancet (London, England) | 2004

von Jocham, D. | Richter, A. | Hoffmann, L. | +8

CommentIn: Lancet. 2004 Feb 21;363(9409):583-4. - PMID 14987879

8

Technology evaluation : PROSTVAC, Therion

enthalten in: Current opinion in molecular therapeutics | 2002

von Doehn, C. | Jocham, D.

1
[1]